GUIZHOU XINBANG PHARMACEUTICAL CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.69 CNY | -0.81% |
|
-3.91% | -16.89% |
| Sales 2022 | 6.35B 877M | Sales 2023 | 6.46B 892M | Capitalization | 8.56B 1.18B |
|---|---|---|---|---|---|
| Net income 2022 | 224M 30.94M | Net income 2023 | 287M 39.64M | EV / Sales 2022 | 1.52 x |
| Net Debt 2022 | 493M 68.15M | Net Debt 2023 | 29.4M 4.06M | EV / Sales 2023 | 1.33 x |
| P/E ratio 2022 |
39.2
x | P/E ratio 2023 |
29.6
x | Employees | 5,149 |
| Yield 2022 |
1.28% | Yield 2023 |
1.35% | Free-Float | 50.7% |
More Fundamentals
* Assessed data
More news
| 1 day | -0.81% | ||
| 1 week | -3.91% | ||
| Current month | -3.15% | ||
| 1 month | -8.21% | ||
| 3 months | -10.44% | ||
| 6 months | -20.99% | ||
| Current year | -16.89% |
1 week
3.60
3.81
1 month
3.604.01
Current year
3.184.66
1 year
3.185.00
3 years
3.1812.00
5 years
3.1812.00
10 years
3.1826.65
| Managers | Title | Age | Since |
|---|---|---|---|
Ling Zhong Kong
CEO | Chief Executive Officer | 56 | 99-12-31 |
Ya Yun Xiao
DFI | Director of Finance/CFO | 51 | 15-05-11 |
Chuan Chen
IRC | Investor Relations Contact | 55 | 14-03-24 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Jin Hu
BRD | Director/Board Member | 48 | 17-02-10 |
Ling Zhong Kong
CEO | Chief Executive Officer | 56 | 99-12-31 |
Jie Qing Zhang
PRN | Corporate Officer/Principal | 49 | 12-02-16 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-18 | 3.69 | -0.81% | 13 969 970 |
| 24-04-18 | 3.72 | -0.53% | 15,902,910 |
| 24-04-17 | 3.74 | +3.60% | 22,360,420 |
| 24-04-16 | 3.61 | -2.70% | 26,065,780 |
| 24-04-15 | 3.71 | -1.85% | 20,761,450 |
End-of-day quote Shenzhen S.E., April 18, 2024
More quotes
GUIZHOU XINBANG PHARMACEUTICAL Co., LTD is a China-based company, principally engaged in the research and development, manufacture and distribution of medical products. The Company operates its businesses through three segments. The Pharmaceutical Manufacturing segment is engaged in the manufacture and distribution of Chinese patent medicines, such as Ginkgo Leaves Tablets. The Pharmaceutical Distribution segment includes rapid wholesale business and medicine retail business. The Medical Services segment is engaged in the provision of medical services. It operates its businesses primarily in domestic markets.
Sector
Pharmaceuticals
Calendar
2024-04-28
- Q1 2024 Earnings Release
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -16.89% | 980M | |
| +40.86% | 6.16B | |
| -16.30% | 4.49B | |
| -9.93% | 3.17B | |
| -1.58% | 3.01B | |
| -1.70% | 2.57B | |
| +37.23% | 1.8B | |
| -12.78% | 1.62B | |
| +1.02% | 1.56B | |
| -12.97% | 1.53B |
- Stock Market
- Equities
- 002390 Stock
